Patients who develop atrial fibrillation (AFib) after surgery face a higher risk of being hospitalized for heart failure, according to new data published in the European Heart Journal.[1]

The…

Cancer survivors appear to be at significantly higher risk for cardiovascular disease, including heart failure and stroke, according to a …

Heart failure patients with limited English proficiency (LEP) often experience worse outcomes, including higher readmission rates. What can cardiologists and other healthcare professionals do to reverse that trend? A team of…

The first human patient to receive a genetically modified pig heart likely died from heart failure, according to an updated analysis from the University of Maryland Medical Center (UMMC) in…

A new study to examine the relationship between extreme-heat events and cardiovascular mortality found that the hottest days can indeed be deadly. …

The U.S. Food and Drug Administration (FDA) has announced an additional recall associated with Medtronic’s HeartWare Ventricular Assist Device (HVAD). This is a Class I recall, which means using the…

While a vast majority of heart transplants (HT) in the United States are successful, unplanned hospitalizations are still incredibly common. In fact, one…

Corvia Medical has raised $54 million from existing investors to continue researching the safety and effectiveness of its Corvia Atrial Shunt, a transcatheter solution designed to treat heart failure with preserved ejection fraction (…

Researchers in Australia believe they’ve made a discovery that could improve care for patients with cardiac hypertrophy, sharing their findings in Nature Cardiovascular Research.[1]

The team’…

The U.S. Food and Drug Administration (FDA) has announced that Medtronic is once again recalling its HeartWare Ventricular Assist Device (HVAD) pump implant kit, a part of the company’s HeartWare…

Among hospitalized heart failure (HF) patients, cocaine use is associated with higher risks of long-term mortality and readmission within 90 days,…

Researchers from the Yale School of Medicine have found that electronic health record (EHR) alerts can help improve the quality of care for outpatients with…

Heart failure patients with a left ventricular assist device (LVAD) spend a significant amount of time engaging in healthcare outside of the home,…

Empagliflozin, an SGLT2 inhibitor approved by the U.S. Food and Drug Administration for the treatment of type 2 diabetes and…

Interventional cardiologists and other heart specialists from all over the world traveled to Atlanta this week for SCAI 2022, the 45th annual meeting of the Society for Cardiovascular Angiography and…

History was made in January when, at the University of Maryland Medical Center (UMMC) in Baltimore, a genetically modified pig heart was…

A team of cardiologists and surgeons at Hackensack University Medical Center in New Jersey believe they have made history by…

Medical researchers have stayed busy in recent years working to develop new interventional heart failure treatments that offer more relief than…

The U.S. Food and Drug Administration (FDA) has approved mavacamten, sold by Bristol Myers Squibb (BMS) under the name Camzyos, for the treatment of adult patients…

Hospitalizations for heart failure (HF) are on the rise among young adults, according to a new study published in JACC: Heart Failure.[1]…

The Penn State College of Medicine has received more than $3 million from the National Heart, Lung and Blood Institute to develop an implantable, wireless…